Dr. Adas Darinskas (born 3rd June 1978) is a renowned Lithuanian scientist and businessman, holding a Doctorate in Biomedical Sciences from Vilnius University. Dr. Darinskas has established several leading biotech companies focused on advanced immunological treatments for oncology and other debilitating illnesses.
Dr. Adas Darinskas has studied at Vilnius University focusing his scientific interests in molecular biology and genetics. In 2008 graduating with a PhD degree in Biomedical Sciences. Dr. Darinskas’ doctoral thesis concentrated on the "Isolation, characterization, transplantation of mouse fetal cells, evaluation of anti-inflammatory effects in mice and application to in vitro toxicity studies".
Later on, in 2016, Dr. Darinskas has been granted an additional Master’s degree at the University of Granada, which has certified him as a Qualified Person in Advanced Therapy Medicinal Products (ATMPs).